Dr. Bennett is featured or cited in the following articles:
Amanda Leech Was Denied the Only Treatment that Eased Her Depression. Now She’s Gone.
By Curt Petrovich
May 6, 2021
Mind the ketamine education gap: Serious adverse events in clinical ketamine treatment – FEATURED
By Raquel Bennett, Psy.D. and Christian Yavorsky, Ph.D.
March 19, 2021
Group ketamine-assisted psychotherapy: Practice and promises of a new frontier
By Sean Lawlor
March 10, 2021
Elijah McClain’s death spotlights ketamine use in law enforcement actions
By Nicholas Powers and Ann Harrison
August 6, 2020
Safety of repeated administration of parenteral ketamine for depression
By David Feifel, M.D. and David Dadiomov, Pharm.D. and Kelly Lee, Pharm.D.
July 13, 2020
Proposed patent for ketamine treatment challenged by clinicians
By Ali McGhee and Ann Harrison
July 1, 2020
Promise, power, and profit: The economics of ketamine treatment
By Raquel Bennett, Psy.D. and Alexander Belser, Ph.D.
Ketamine for depression and mood disorders
By Erica Zelfand, N.D.
Visions to heed: Ketamine’s breakout in psychedelic therapy
By Dan Bernitt
May 1, 2019
Paradigms of ketamine treatment – FEATURED
By Raquel Bennett, Psy.D.
Listening to ketamine
By Emily Underwood
March 29, 2019
Psychedelic feminism: A radical interpretation of psychedelic consciousness?
Journal for the Study of Radicalism
By Kim Hewitt, Ph.D.
Cited on pp. 97-99
Ketamine KRIYA Conference 2018: The most phenomenal ketamine conference to date!
By Lori Calabrese, M.D.
November 21, 2018
Rapid depression remission and the “therapeutic bends” with ketamine-assisted psychotherapy
By Jessica Katzman, Psy.D.
September 8, 2018
Ketamine stirs up hope – and controversy – as a depression drug
By Moises Velasquez-Manoff
Opportunities and strategies for a ketamine psychotherapeutics (KAP)
The Ketamine Papers
By Phil Wolfson, M.D.
Cited on pp. 339-340